Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 11, 2009, Pages 1824-1831

  Castaman, G ^a   Mancuso, M E ^b   Giacomelli, S H ^a   Tosetto, A ^a   Santagostino, E ^b   Mannucci, P M ^b   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Desmopressin; Factor VIII; FVIII gene mutation; Mild hemophilia A; Von Willebrand factor

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8C; DESMOPRESSIN; EMOSINT; GENOMIC DNA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE SEVERITY; DNA SEQUENCE; DRUG RESPONSE; EXON; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEMOPHILIA A; HUMAN; INTRON; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

ADULT; AGED; COHORT STUDIES; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; GENE COMPONENTS; HEMOPHILIA A; HUMANS; MIDDLE AGED; MUTATION; PHENOTYPE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 70449421615     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03595.x     Document Type: Article

References (31)

1. Mannucci PM. Desmopressin (DDAVP) for treatment of disorders of hemostasis. Prog Hemostas Thromb 1986, 8:19-45.
2. Castaman G. Desmopressin for the treatment of haemophilia. Haemophilia 2008, 14(Suppl. 1):15-20.
3. Mannucci PM, Ghirardini A. Desmopressin: twenty years after. Thromb Haemost 1997, 78:958.
4. De la Fuente B, Kasper CK, Rickles FR, Hoyer LW. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med 1985, 103:6-14.
5. Mariani G, Ciavarella N, Mazzucconi MG, Antoncecchi S, Solinas S, Ranieri P, Pettini P, Agrestini F, Mandelli F. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients. Clin Lab Haematol 1984, 6:229-38.
6. Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA, Bloom AL. Factor VIII and fibrinolytic response to deamino-8-D-Arginine Vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Br J Haematol 1980, 45:499-504.
7. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981, 47:283-8.
8. Mannucci PM, Vicente V, Alberca I, Sacchi E, Longo G, Harris AS, Lindquist A. Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses. Thromb Haemost 1987, 58:1037-9.
9. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Battle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006, 4:766-73.
10. Casonato A, Pontara E, Zerbinati P, Zucchetto A, Girolami A. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998, 109:347-52.
11. Oldenburg J, Ivaskevicius W, Rost S, Fregin A, White K, Holinski-Feder E, Müller CR, Weber BH. Evaluation of DHPLC in the analysis of hemophilia A. J Biochem Biophys Methods 2001, 47:39-51.
12. Acquila M, Pasino M, Lanza T, Bottini F, Molinari AC, Bicocchi MP. Duplication of exon 13 causes one-third of cases of mild hemophilia A in northern Italy. Haematologica 2004, 89:758-9.
13. Castaman G, Giacomelli SH, Ghiotto R, Boseggia C, Pojani K, Bulo A, Rodeghiero F. Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII gene. Haemophilia 2007, 13:311-6.
14. El-Maarri O, Herbiniaux U, Graw J, Schröder J, Terzic A, Watzka M, Brackmann HH, Schramm W, Hanfland P, Schwaab R, Müller CR, Oldenburg J. Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. J Thromb Haemost 2005, 3:332-9.
15. http://europium.csc.mrc.ac.uk, HAMSTeRS Database. . Accessed 19 June 2008
16. Jacquemin M, De Maeyer M, D'Oiron R, Lavend'homme R, Peerlinck K, Saint-Remy J-M. Molecular mechanisms of mild and moderate hemophilia A. J Thromb Haemostas 2003, 1:456-63.
17. Rodeghiero F, Castaman G, DiBona E, Ruggeri M. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A. Blood 1989, 74:1997-2000.
18. Nolan B, White B, Smith J, O'Reily C, McMahon C, Fitzpatrick B, Smith OP. Desmopressin: therapeutic limitations in children and adults with inherited bleeding disorders. Br J Haematol 2000, 109:865-9.
19. Revel-Vilk S, Blanchette V, Sparling C, Stain AM, Carcao MD. DDAVP challenge tests in boys with mild/moderate haemophilia A. Br J Haematol 2002, 117:947-51.
20. Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ. Factor VIII and von Willebrand Factor. Thromb Haemost 1998, 79:456-65.
21. Fijnvandraat K, Peters M, Ten Cate JW. Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor levels. Br J Haematol 1995, 91:474-6.
22. Morfini M. Pharmacokinetics of factor VIII and factor IX. Haemophilia 2003, 9(Suppl. 1):94-100.
23. Castaman G, Lethagen S, Federici AB, Tosetto A, Goodeve A, Budde U, Batlle J, Meyer D, Mazurier C, Fressinaud E, Goudemand J, Eikenboom J, Schneppenheim R, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Pasi J, Hill F, Peake I. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008, 111:3531-9.
24. Bogdanova N, Markoff A, Eisert R, Wermes C, Pollman H, Todorova A, Chlystun M, Nowak-Göttl U, Horst J. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat 2007, 28:54-60.
25. Pemberton S, Lindley P, Zaitsev V, Card G, Tuddenham EG, Kemball-Cook G. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 1997, 89:2413-21.
26. Peerlinck K, Jacquemin MG, Arnout J, Hoylaerts MF, Gilles JG, Lavend'homme R, d'Oiron R, Schwaab R, Bakkus M, Thielemans K, Gilles JG, Vermylen J, Saint-Remy JM. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A. Blood 1999, 93:2267-73.
27. Liu ML, Shen BW, Nakaya S, Pratt KP, Fujikawa K, Davie EW, Stoddard BL, Thompson AR. Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure. Blood 2000, 96:979-87.
28. d'Oiron R, Volot F, Reynaud J, Peerlinck K, Goudemand J, Guérois C, Rothschild C, Chambost H, Borel-Derlon A, Roussel-Robert V, Marquès-Verdier A, Lienhart A, Berthier AM, Moreau P, Lambert T. Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia A and inhibitors. Semin Hematol 2006, 43(Suppl. 1):S3-9.
29. Santacroce R, Santoro R, Sessa F, Iannaccaro P, Sarno M, Longo V, Gallone A, Vecchione G, Muleo G, Margaglione M. Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in Southern Italy. Blood Coagul Fibrinolysis 2008, 19:197-202.
30. Hay CR. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Haemophilia 1998, 4:558-63.
31. Kesteven PJ, Holland LJ, Lawrie AJ, Savidge GF. Inhibitor to factor VIII in mild hemophilia. Thromb Hemost 1984, 52:50-3.